SlideShare uma empresa Scribd logo
1 de 62
Baixar para ler offline
Canada: Florida’s Innovation, Investment
   and International Biotech Partner


          Life Sciences Breakfast
          Tampa, February 1, 2010
Overview



Background
Canada
Florida
Opportunities
Partnerships


                       2
Background
Department of Foreign Affairs and
International Trade Canada (DFAIT)




Canada has diplomatic and consular offices in over
Canada has diplomatic and consular offices in over
        270 locations in 180 countries.
         270 locations in 180 countries.
                                                     4
Canada’s Footprint in North America




                                      5
Canada-U.S. Relations


Canada and the U.S., a strong partnership

Geography, History, Security and Business

Canada is Florida’s #1 Economic Partner

Common industrial strengths, both depend
heavily on international commerce

Canada 8th largest economy worldwide,
Florida about 15th.                         6
Market Access




           500 km


                                                                                                                              St. John's
           1000 km
                              Edmonton
                                       Saskatoon                                      Québec                        Charlottetown
                   Calgary          Regina
                                               Winnipeg                              Fredericton                    Halifax
Victoria        Vancouver                                                     Ottawa      Montréal
                Seattle
                                                           Milwaukee
                                                                             Toronto           Boston
                                                                          Windsor             New York
                                                                Chicago               Cleveland
                                                                        Detroit                      Philadelphia
                                                                             Pittsburgh         Baltimore
                                                              St. Louis                         Washington


           San Francisco             Denver


                                                                                   Atlanta
                Los Angeles


                                                 Houston

                                                                                                  Miami




                                         Mexico City




                                                                                                                                           7
Largest Trading Partner




                          8
Largest Foreign Investor


Investment = Influence




                           9
A Top Investor in Florida



            Top Foreign Investors in Florida
     By Value (billions)                By Jobs
Germany                        UK
                       $3.8                       45,200

Japan                          Netherlands
                      $3.79                       24,000

UK                             Canada
                      $3.69                       23,100

Canada                         Germany
                      $2.99                       22,400

Australia             $2.77    Japan               21,20




                                                           10
Canadian Businesses




                      11
Canadian Businesses




                      12
Canada
Canadian Health Care Market


Population: 33.5 million

High health expenditure: CAD $5170 p.p.

Long life expectancy: 81.6 years

$20B drug market, $6B in medical devices, Top 10 globally

Highly profitable: 13% average profit margins

Bio-based economy worth $78.3 billion (6.5% of GDP, similar in
size to auto) and is responsible for 1 million jobs.
Industry Snapshot



Home to 3rd largest Life Sciences industry in the world


Key strengths:
   Biopharmaceutical R&D
   Medical devices
   Contract services

Leading scientific excellence




                                                          15
Life Science Clusters In Canada

                                                                                                Atlantic Canada
                                                                                                •30 companies
                                                                                                •200 employees (1%)
   British Columbia                                                                             •$25 M in annual R&D
   •110 companies                                                                               • Nutraceuticals &
   •2500 employees (15%)                                                                        Marine Bioscience
   •$300 M in annual R&D
   • Genomics
  Prairies
  •110 companies
  •1800 employees (11%)                       Ontario:
                                                                                            Quebec
  •$200 M in annual R&D                       •220 companies
                                                                                            •240 companies
  • Bioimaging                                •6000 employees (38%)
                                                                                            •5500 employees (35%)
                                              •$650 M in annual R&D
                                                                                            •$600 M in annual R&D
                                              • Stem Cells
                                                                                            • Vaccine Research
                                              • Drug Development
Source: Industry Canada, Statistics Canada, PMPRB. Statistics are for Private sector only

                                                                                                                       16
Pharmaceutical Industry Snapshot


$20 billion domestic
market

100+ companies with
40,000+ employees

Market dominated by
foreign multinationals

$1.5 billion in R&D
spending

Over $4 billion in exports


                                               17
Consumer Pharmaceutical Spending


Total annual spending (prescription drugs): $19.3 billion
              Brand name: $15.2 billion (78.6%)
              Generic: $4.1 billion (21.4%)
             Average cost per prescription, $CAD




                                                            18
Biopharmaceutical Industry Strengths


• Discovery & characterization of therapeutic molecules

• Genomics & proteomics platforms

• Vaccines & immuno-therapeutics

• Regenerative medicine & stem cell research

• Drug formulation & delivery systems

• Oncology/cancer research

• Generic pharmaceuticals
Major Global Investors in Canada




                                   20
Top Sales Leaders in 2008

Leading Pharmaceutical Companies in Canada in 2008

                                           Total
            Leading        R&D Location                 Market
Rank


                                        Purchases
           Companies        in Canada                  Share (%)
                                        ($ Billions)
 1     Pfizer                Montreal       2.57         12.7
 2     Apotex                 Toronto       1.52          7.5
 3     AstraZeneca           Montreal       1.34          6.6
 4     Johnson & Johnson      Toronto       1.10          5.5
 5     GlaxoSmithKline        Toronto       0.97          4.8
 6     Novopharm              Toronto       0.83          4.1
 7     Novartis               Toronto       0.75          3.7
 8     Abbott                Montreal       0.72          3.6
 9     Schering-Plough       Montreal       0.68          3.4
10     Roche                 Montreal       0.62          3.1

                                                                   21
Recent Investments In Canada



Sanofi Pasteur
• $100M: vaccine R&D facilities in Toronto



AstraZeneca Canada Inc.
• $10M: pain control research centre in Montreal



Glaxo Smith Kline (GSK)
• $199M: vaccine production facility in Québec
• $50M: vaccine R&D headquarters in Montreal
Leading Canadian Companies
        (Some Examples)




         Company                  Focus
         Apotex                   Generics manufacturing
                                  Theranostics: detection of protein
         Amorfix
                                  misfolding
                                  CNS disorders, pain management, &
         Biovail
                                  cardiovascular disease
         BioNiche Life Sciences   Oncology & animal vaccines
         Cangene                  Mfg. of Ab.’s, peptides, & vaccines
         DiaMedica                Therapy for Type II diabetes
         ImmunoVaccine
                                  Vaccine innovation & development
         Technologies
                                  Controlled-release technologies for
         Labopharm
                                  small molecule drugs
         NAEJA                    NCE discovery & synthesis
                                  Mfg of natural, recombinant, &
         Prometic Life Sciences
                                  synthetic proteins
         Theratechnologies        Peptide-based therapeutics


                                                                        23
Medical Device Industry Snapshot


$6 billion market

$2 billion in exports; $4 billion in
imports

Majority of revenues to
multinationals & distributors

200+ developers/manufacturers
(90% Canadian owned)

94% of firms have < 50 employees


                                              24
Major Global Investors in Canada




                                   25
Leading Canadian Companies
                                                (Some Examples)



Company            Focus

                   TAXUS® drug-eluting
Angiotech
                   coronary stent

ART                Optical molecular imaging


EastMed            Uresta® bladder support


                   Blood diagnostic system in
Epocal
                   FlexCard™ technology

                   IMRISneuro, Intra-
IMRIS
                   operative MRI

                   Radiological imaging &
MDS Nordion
                   isotopes

Novadaq
                   Operating room imaging
Technologies

Pyng Medical       First Aid Devices

Resonant Medical   3D Ultrasound Imaging

Urodynamix         Urology diagnostics
                                                                  26
Leading Canadian Companies
        (Some Examples)




           Company               Focus
           Axela                 Protein interaction technology
           BrightWELL            Micro-Flow imaging technology
           Techologies           (MFI) for cell analysis
                                 DNA collection & preservation
           DNA Genotek
                                 systems
           QBM Cell Science
                                 Cryopreserved mouse neurons

                                 Advanced medical polymers &
           Rimon Therapeutics
                                 biomaterials for wound care
           Spartan Biosciences   Personal DNA analyzers
                                 Fast testing of Sepsis & West
           Spectral Diagnostic
                                 Nile Virus




                                                                  27
Medical Device Strengths

In-vitro diagnostics
Medical imaging & analysis
Nuclear medicine
Surgical & implant devices
Advanced materials & nanotechnology




                                      28
In-Vitro Diagnostics

                   Examples Include:




Epocal’s Blood Diagnostic      Spectral Diagnostic’s
  System in FlexCard™         Testing Kit for West Nile
       Technology                      Virus


                                                          29
Medical Imaging & Analysis

                    Examples Include:




   ART’s SoftScan                   IDC’s DR System
Breast Imaging Device

                                                      30
Nuclear Medicine

        Examples Include:




MDS Nordion’s Glucotrace® for Cardiology and
  Oncology Diagnoses using PET Isotopes
                                               31
Surgical & Implant Devices

                               Examples Include:


Angiotech’s
Drug-Eluting
 Coronary
   Stents




                             EastMed’s Uresta® for Stress Urinary
                                  Incontinence for Women

                                                                    32
Latest Innovation


World’s First Simulation-Based Brain Surgery Done in Halifax, Canada
                              2009.08




                                                                   33
Canada’s Contract Services Subsector



THEN: Provided backup supply services to multinational
       pharmaceutical companies

NOW: Grown and become technologically sophisticated
  World renowned for quick recruiting
  Adheres to GCP protocols & generates high quality, robust
  data
  4th worldwide in overall share of global clinical trials
  Top 10 pharmaceutical companies consistently include
  Canada in clinical development plans & new drug submission
  data packages
Contract Services: Strengths


Contract manufacturers (CMOs)


 Clinical research organizations
(CROs)


 Design & manufacturing of high
value medical devices (surgical
devices, implants, imaging systems)


Analytical services


Regulatory affairs & compliance
                                               35
Leading Canadian Companies

Company                       Focus
                              Research contracting organization specializing in pre-clinical, phase I & bioequivalence
Algorithme Pharma
                              studies
                              Clinical trial management company managing multi-site trials & sourcing trial services
Allphase Clinical Research
                              globally
                              Manufacturing contracts for both large and small-molecule Advanced Pharmaceutical
Biovectra
                              Ingredients (API’s), advanced intermediates, and cGMP bioprocessing reagents

MDS Pharma Service            Research contracting organization that provides drug discovery and development services

                              Manufacturing contractors committed to the development, manufacturing, purification, and
Therapure Biopharma
                              packaging of high-quality biological therapeutics

Wellspring Pharmaceutical     Manufacturing contracts for specialized dosage forms for clinical & commercial distribution




                                                                                                                            36
Clinical Trials by Condition




Source: ClinicalTrials.gov, Dec. 2008
                                                           37
Clinical Trials by Sponsor




                             38
Florida
Emerging Biotech Cluster


Why is Canada interested?
   Top 10 US biotech clusters
   US $10b+ NIH funding, most research
   intensive country in the world, 50% and 40%
   of global patent applications in med tech
   and pharma/biotech products, respectively
   Paradigm shift: globalization of industry and
   BigPharma looking to fill innovation gap as
   blockbuster revenue cliff approaches

Weaknesses in Florida
   VC funding
   Training/Tertiary Education/Skilled Labour
   Entrepeneurship


                                                   40
Opportunities
Strategic Context


Post-recession
 • Technology based firms need international linkages to position themselves for the
   post-recession economy.
 • By partnering with other countries on science and technology, firms connect to
   knowledge, know-how, people, investments and markets abroad.
 • They also respond to new business model where “biotech clusters will be
   redefined away from geography and be more virtual built around diseases,
   pathways, markets, and unique industry segments”. (Burrill & Co. Biotech 2010 –
   Life Sciences: Adapting for Success).
Credit Crunch, Public & Private Capital Drought
 • VC funding lowest in 15 years both in Canada and the U.S.: ($1 billion in Canada,
    $235 million in Florida) – however healthcare surpassed IT or cleantech.
 • PE/Buyout market: Canada 4th in volume, 18th in value of M&A deals, however
    Canadian funds raised close to $20 billion in 2006-2008 so considerable available
    capital to deploy.
 • Only 3 biotech IPOs in 2009, but Burrill expects pick-up to 15 IPOs in 2010


                                                                                        42
Five major factors
      drive foreign interest in collaborations



       Attractions include Canada’s:
• Strong and stable economy
• First-class technological infrastructure
• Highly skilled workforce
• Lower business and R&D cost structure
• Investment incentive programs: the best
  research incentives in the world




                                                 43
Workforce: Educated & Available


                         Higher Education Achievement

    55   54,0
                53,0
                       51,4   51,0
                                     50,0
    50                                       47,8

    45
%




                                                     41,0    41,0    41,0
                                                                             40,0   40,0   39,8
    40                                                                                            39,0   39,0


    35

    30
                         a




                                          ng
                         e




                                            k
                                         um




                                De y
        da




                                                                                               ce
                                         an




                                           d
                         n




                               Ho ain
                                            l




                                                                                                      S.
                                        ae
                       re




                                         ar
                                          a
             So por




                                       lan
                      pa




                                      Ko
                                      rw
      na




                                                                                                    U.
                                                                                             an
                                      iw




                                   nm
                    Ko




                                   Sp
                                     lgi
                                    Isr
                   Ja




                                  Ire
                    a




                                  Ta




                                 No




                                                                                           Fr
    Ca




                                 Be
                ng




                                 ng
                  h
               ut
              Si




                              Source: IMD, World Competitiveness Yearbook 2008
                                                                                                                44
Workforce: Educated & Available




    Source: IMD, World Competitiveness Yearbook 2008
                                                       45
Low Labor Costs




                  46
Thriving Clusters




                    47
Quality Living Environment




                             48
Canada: An Innovation Leader

Canada generates about 4% of global knowledge, as measured by
academic publications, a formidable statistic considering it
composes only 1% of the global population.
Canada leads the G7 in public sector research funding on a per
capita basis.
Canada has one of the most generous tax-based support
programs in the industrialized world through the Scientific
Research & Experimental Development tax credit.




                                                                 49
Canadian Life Sciences Innovation

Canada’s health science research community consists of over
64,000 physicians, 30,000 investigators in 17 medical schools, and
over 100 teaching hospitals and research institutes.
Canadian innovators are internationally recognized for research
and product development excellence in genomics,proteomics,
vaccine development, medical devices, regenerative medicine
(stem cells), protein engineering, immunotherapies and drug
delivery systems.
Canada Canadian life sciences discoveries: insulin, pacemaker,
sequencing Alzheimer genome & H1N1 genome, adult stem cells,
how stem cells become blood cells, embryonic stem cells from
skin, etc.




                                                                     50
Canadian university R&D
                           funding programs

•   Canadian Institutes of Health Research (CIHR)
•   Canada Foundation for Innovation (CFI)
•   Canada Research Chairs (CRC)
•   Genome Canada
•   Networks of Centres of Excellence (NCE)
•   Department of Foreign Affairs and International Trade
•   National Research Council:
     • 15 Industrial Partnership Facilities (IPF)
     business incubators affiliated with NRC’s 21
     research institutes -137 firms, 13 graduates 08-09
     • Industry Research Assistance Program (IRAP)
     works with 8000 SMEs, youth internships, Angiotech (anti-
       inflammation tech) in 5 years $30 milllions 1,500 jobs
                                                                 51
Innovation and Sector Interface


                                 Life Sciences

                                                 ICT
                                            Clean Tech
                                                         Aerospace

$            Pu
                                Valley of
                b   lic          Death


                            e
                       iv at
                     Pr




Mind                                                     Market      52
Investment


Growth Capital




                        2009
                        TSX: 28 IPOs, $1.8billion
                        TSX-V: 20 IPOs, $69 million
                        2010 (projected)
                        TSX & TSX-V: $4 billion IPO market
                                                             53
Events in Canada


BioPartnering North America, Vancouver, Jan 24-26, 2010




BioFinance, Toronto, 6-8 April, 2010




BioContact, Quebec City, Oct. 6-7, 2010



                                                          54
Partnerships
Success Stories


Stem Cells




                               56
Success Stories


Drug Development




                                     57
Success Stories


Research/Education/Simulation/Commercialization




                                                  58
Success Stories


AIDS/Immunology




                                    59
Success Stories


And more…




                              60
Conclusion



Tap into Canadian ideas, knowledge and talent – through
strategic alliances, joint ventures, licensing and technology
transfer agreements, and venture capital as well as public and
private equity investments.


Explore the opportunities to make Canadian innovators your
technology development and commercialization partners.




                                                                 61
Contact Info
 http://twitter.com/claudiopramirez

 http://www.linkedin.com/in/claudiopramirez

 http://www.facebook.com/claudiopramirez

Mais conteúdo relacionado

Semelhante a Canada Life Sciences Breakfast Tampa Feb 2010

Presentación TechBa - Csoftmty
Presentación TechBa - CsoftmtyPresentación TechBa - Csoftmty
Presentación TechBa - CsoftmtyCsoftmty Monterrey
 
About proactive investors presentation sept 2011
About proactive investors presentation sept 2011About proactive investors presentation sept 2011
About proactive investors presentation sept 2011frisblue
 
2012 National Governors Association Growing State Economies Summit
2012 National Governors Association Growing State Economies Summit2012 National Governors Association Growing State Economies Summit
2012 National Governors Association Growing State Economies SummitJack Brittain
 
Invest in Toronto Region: Accelerate Innovation to Drive Competitive Advantage
Invest in Toronto Region: Accelerate Innovation to Drive Competitive AdvantageInvest in Toronto Region: Accelerate Innovation to Drive Competitive Advantage
Invest in Toronto Region: Accelerate Innovation to Drive Competitive AdvantageToronto Region Research Alliance
 
Dubai Learnings Presentation Final
Dubai Learnings Presentation FinalDubai Learnings Presentation Final
Dubai Learnings Presentation FinalDrew Lein
 
PwC: What private companies should know about emerging markets
PwC: What private companies should know about emerging marketsPwC: What private companies should know about emerging markets
PwC: What private companies should know about emerging marketsviarocci001
 
2009 Tinsley Inc Programs
2009 Tinsley Inc Programs2009 Tinsley Inc Programs
2009 Tinsley Inc Programsdvrkid
 
The ADD Effect In Clinical Development
The ADD Effect In Clinical DevelopmentThe ADD Effect In Clinical Development
The ADD Effect In Clinical DevelopmentSanjay Modi
 
[PreMoney MENA 2015] Commerce Ventures >> Dan Rosen, "THE NEXT GREAT DISRUPTO...
[PreMoney MENA 2015] Commerce Ventures >> Dan Rosen, "THE NEXT GREAT DISRUPTO...[PreMoney MENA 2015] Commerce Ventures >> Dan Rosen, "THE NEXT GREAT DISRUPTO...
[PreMoney MENA 2015] Commerce Ventures >> Dan Rosen, "THE NEXT GREAT DISRUPTO...500 Startups
 
The Biotech City: your north american gateway to biosuccess
The Biotech City: your north american gateway to biosuccessThe Biotech City: your north american gateway to biosuccess
The Biotech City: your north american gateway to biosuccessLaval Technopole
 
Cold-chain Market prospects in India
Cold-chain Market prospects in IndiaCold-chain Market prospects in India
Cold-chain Market prospects in IndiaPawanexh Kohli
 
Mark Bowles presentation on the San Diego Startup Ecosystem
Mark Bowles presentation on the San Diego Startup EcosystemMark Bowles presentation on the San Diego Startup Ecosystem
Mark Bowles presentation on the San Diego Startup EcosystemMarco Thompson
 
Digital Look Media Pack
Digital Look Media PackDigital Look Media Pack
Digital Look Media Packdigitallook
 
D2 challenger point
D2 challenger pointD2 challenger point
D2 challenger pointJon Morgan
 
Мark Phillips "Intoduction to Silicon Valley"
Мark Phillips "Intoduction to Silicon Valley"Мark Phillips "Intoduction to Silicon Valley"
Мark Phillips "Intoduction to Silicon Valley"Agile Base Camp
 
Publishing excel charts and power points presentation
Publishing excel charts and power points presentationPublishing excel charts and power points presentation
Publishing excel charts and power points presentationGisell20
 

Semelhante a Canada Life Sciences Breakfast Tampa Feb 2010 (20)

Presentación TechBa - Csoftmty
Presentación TechBa - CsoftmtyPresentación TechBa - Csoftmty
Presentación TechBa - Csoftmty
 
Nola bio lunch 2012(4)
Nola bio lunch 2012(4)Nola bio lunch 2012(4)
Nola bio lunch 2012(4)
 
About proactive investors presentation sept 2011
About proactive investors presentation sept 2011About proactive investors presentation sept 2011
About proactive investors presentation sept 2011
 
2012 National Governors Association Growing State Economies Summit
2012 National Governors Association Growing State Economies Summit2012 National Governors Association Growing State Economies Summit
2012 National Governors Association Growing State Economies Summit
 
Investment Management Proposal $100 Mill
Investment Management Proposal $100 MillInvestment Management Proposal $100 Mill
Investment Management Proposal $100 Mill
 
Invest in Toronto Region: Accelerate Innovation to Drive Competitive Advantage
Invest in Toronto Region: Accelerate Innovation to Drive Competitive AdvantageInvest in Toronto Region: Accelerate Innovation to Drive Competitive Advantage
Invest in Toronto Region: Accelerate Innovation to Drive Competitive Advantage
 
RFCD 2011: Andrew Crawford: Cluster Development Costa Rica
RFCD 2011: Andrew Crawford: Cluster Development Costa RicaRFCD 2011: Andrew Crawford: Cluster Development Costa Rica
RFCD 2011: Andrew Crawford: Cluster Development Costa Rica
 
Dubai Learnings Presentation Final
Dubai Learnings Presentation FinalDubai Learnings Presentation Final
Dubai Learnings Presentation Final
 
PwC: What private companies should know about emerging markets
PwC: What private companies should know about emerging marketsPwC: What private companies should know about emerging markets
PwC: What private companies should know about emerging markets
 
Iucn-shell
Iucn-shellIucn-shell
Iucn-shell
 
2009 Tinsley Inc Programs
2009 Tinsley Inc Programs2009 Tinsley Inc Programs
2009 Tinsley Inc Programs
 
The ADD Effect In Clinical Development
The ADD Effect In Clinical DevelopmentThe ADD Effect In Clinical Development
The ADD Effect In Clinical Development
 
[PreMoney MENA 2015] Commerce Ventures >> Dan Rosen, "THE NEXT GREAT DISRUPTO...
[PreMoney MENA 2015] Commerce Ventures >> Dan Rosen, "THE NEXT GREAT DISRUPTO...[PreMoney MENA 2015] Commerce Ventures >> Dan Rosen, "THE NEXT GREAT DISRUPTO...
[PreMoney MENA 2015] Commerce Ventures >> Dan Rosen, "THE NEXT GREAT DISRUPTO...
 
The Biotech City: your north american gateway to biosuccess
The Biotech City: your north american gateway to biosuccessThe Biotech City: your north american gateway to biosuccess
The Biotech City: your north american gateway to biosuccess
 
Cold-chain Market prospects in India
Cold-chain Market prospects in IndiaCold-chain Market prospects in India
Cold-chain Market prospects in India
 
Mark Bowles presentation on the San Diego Startup Ecosystem
Mark Bowles presentation on the San Diego Startup EcosystemMark Bowles presentation on the San Diego Startup Ecosystem
Mark Bowles presentation on the San Diego Startup Ecosystem
 
Digital Look Media Pack
Digital Look Media PackDigital Look Media Pack
Digital Look Media Pack
 
D2 challenger point
D2 challenger pointD2 challenger point
D2 challenger point
 
Мark Phillips "Intoduction to Silicon Valley"
Мark Phillips "Intoduction to Silicon Valley"Мark Phillips "Intoduction to Silicon Valley"
Мark Phillips "Intoduction to Silicon Valley"
 
Publishing excel charts and power points presentation
Publishing excel charts and power points presentationPublishing excel charts and power points presentation
Publishing excel charts and power points presentation
 

Mais de Embassy of Canada to the UAE

Mais de Embassy of Canada to the UAE (7)

Les learning week report miami
Les learning week report   miamiLes learning week report   miami
Les learning week report miami
 
Social Media Training
Social Media Training Social Media Training
Social Media Training
 
Canada's commercial relations with Florida and the Caribbean region
Canada's commercial relations with Florida and the Caribbean regionCanada's commercial relations with Florida and the Caribbean region
Canada's commercial relations with Florida and the Caribbean region
 
Canada, Florida's Largest Economic Partner
Canada, Florida's Largest Economic PartnerCanada, Florida's Largest Economic Partner
Canada, Florida's Largest Economic Partner
 
Canada Presentation at ACG Orlando
Canada Presentation at ACG OrlandoCanada Presentation at ACG Orlando
Canada Presentation at ACG Orlando
 
How Canada Promotes International Trade
How Canada Promotes International TradeHow Canada Promotes International Trade
How Canada Promotes International Trade
 
Profil de Marché et Opportunités d'Affaires avec la Floride
Profil de Marché et Opportunités d'Affaires avec la FlorideProfil de Marché et Opportunités d'Affaires avec la Floride
Profil de Marché et Opportunités d'Affaires avec la Floride
 

Último

UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGlokeshwarmaha
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...Brian Solis
 
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)tazeenaila12
 
Upgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsUpgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsIntellect Design Arena Ltd
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyHanna Klim
 
PDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfPDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfHajeJanKamps
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessAPCO
 
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptxHELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptxHelene Heckrotte
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfAnhNguyen97152
 
Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..dlewis191
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024Stephan Koning
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsP&CO
 
Tata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakTata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakEditores1
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinAnton Skornyakov
 
Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Winbusinessin
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Reportamberjiles31
 
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfSourav Sikder
 

Último (20)

UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
 
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
 
Upgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsUpgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking Applications
 
WAM Corporate Presentation Mar 25 2024.pdf
WAM Corporate Presentation Mar 25 2024.pdfWAM Corporate Presentation Mar 25 2024.pdf
WAM Corporate Presentation Mar 25 2024.pdf
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agency
 
PDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfPDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdf
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
 
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptxHELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
 
Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizations
 
Tata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakTata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerak
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup Berlin
 
Investment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV IndustriesInvestment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV Industries
 
Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Report
 
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
 

Canada Life Sciences Breakfast Tampa Feb 2010

  • 1. Canada: Florida’s Innovation, Investment and International Biotech Partner Life Sciences Breakfast Tampa, February 1, 2010
  • 4. Department of Foreign Affairs and International Trade Canada (DFAIT) Canada has diplomatic and consular offices in over Canada has diplomatic and consular offices in over 270 locations in 180 countries. 270 locations in 180 countries. 4
  • 5. Canada’s Footprint in North America 5
  • 6. Canada-U.S. Relations Canada and the U.S., a strong partnership Geography, History, Security and Business Canada is Florida’s #1 Economic Partner Common industrial strengths, both depend heavily on international commerce Canada 8th largest economy worldwide, Florida about 15th. 6
  • 7. Market Access 500 km St. John's 1000 km Edmonton Saskatoon Québec Charlottetown Calgary Regina Winnipeg Fredericton Halifax Victoria Vancouver Ottawa Montréal Seattle Milwaukee Toronto Boston Windsor New York Chicago Cleveland Detroit Philadelphia Pittsburgh Baltimore St. Louis Washington San Francisco Denver Atlanta Los Angeles Houston Miami Mexico City 7
  • 10. A Top Investor in Florida Top Foreign Investors in Florida By Value (billions) By Jobs Germany UK $3.8 45,200 Japan Netherlands $3.79 24,000 UK Canada $3.69 23,100 Canada Germany $2.99 22,400 Australia $2.77 Japan 21,20 10
  • 14. Canadian Health Care Market Population: 33.5 million High health expenditure: CAD $5170 p.p. Long life expectancy: 81.6 years $20B drug market, $6B in medical devices, Top 10 globally Highly profitable: 13% average profit margins Bio-based economy worth $78.3 billion (6.5% of GDP, similar in size to auto) and is responsible for 1 million jobs.
  • 15. Industry Snapshot Home to 3rd largest Life Sciences industry in the world Key strengths: Biopharmaceutical R&D Medical devices Contract services Leading scientific excellence 15
  • 16. Life Science Clusters In Canada Atlantic Canada •30 companies •200 employees (1%) British Columbia •$25 M in annual R&D •110 companies • Nutraceuticals & •2500 employees (15%) Marine Bioscience •$300 M in annual R&D • Genomics Prairies •110 companies •1800 employees (11%) Ontario: Quebec •$200 M in annual R&D •220 companies •240 companies • Bioimaging •6000 employees (38%) •5500 employees (35%) •$650 M in annual R&D •$600 M in annual R&D • Stem Cells • Vaccine Research • Drug Development Source: Industry Canada, Statistics Canada, PMPRB. Statistics are for Private sector only 16
  • 17. Pharmaceutical Industry Snapshot $20 billion domestic market 100+ companies with 40,000+ employees Market dominated by foreign multinationals $1.5 billion in R&D spending Over $4 billion in exports 17
  • 18. Consumer Pharmaceutical Spending Total annual spending (prescription drugs): $19.3 billion Brand name: $15.2 billion (78.6%) Generic: $4.1 billion (21.4%) Average cost per prescription, $CAD 18
  • 19. Biopharmaceutical Industry Strengths • Discovery & characterization of therapeutic molecules • Genomics & proteomics platforms • Vaccines & immuno-therapeutics • Regenerative medicine & stem cell research • Drug formulation & delivery systems • Oncology/cancer research • Generic pharmaceuticals
  • 20. Major Global Investors in Canada 20
  • 21. Top Sales Leaders in 2008 Leading Pharmaceutical Companies in Canada in 2008 Total Leading R&D Location Market Rank Purchases Companies in Canada Share (%) ($ Billions) 1 Pfizer Montreal 2.57 12.7 2 Apotex Toronto 1.52 7.5 3 AstraZeneca Montreal 1.34 6.6 4 Johnson & Johnson Toronto 1.10 5.5 5 GlaxoSmithKline Toronto 0.97 4.8 6 Novopharm Toronto 0.83 4.1 7 Novartis Toronto 0.75 3.7 8 Abbott Montreal 0.72 3.6 9 Schering-Plough Montreal 0.68 3.4 10 Roche Montreal 0.62 3.1 21
  • 22. Recent Investments In Canada Sanofi Pasteur • $100M: vaccine R&D facilities in Toronto AstraZeneca Canada Inc. • $10M: pain control research centre in Montreal Glaxo Smith Kline (GSK) • $199M: vaccine production facility in Québec • $50M: vaccine R&D headquarters in Montreal
  • 23. Leading Canadian Companies (Some Examples) Company Focus Apotex Generics manufacturing Theranostics: detection of protein Amorfix misfolding CNS disorders, pain management, & Biovail cardiovascular disease BioNiche Life Sciences Oncology & animal vaccines Cangene Mfg. of Ab.’s, peptides, & vaccines DiaMedica Therapy for Type II diabetes ImmunoVaccine Vaccine innovation & development Technologies Controlled-release technologies for Labopharm small molecule drugs NAEJA NCE discovery & synthesis Mfg of natural, recombinant, & Prometic Life Sciences synthetic proteins Theratechnologies Peptide-based therapeutics 23
  • 24. Medical Device Industry Snapshot $6 billion market $2 billion in exports; $4 billion in imports Majority of revenues to multinationals & distributors 200+ developers/manufacturers (90% Canadian owned) 94% of firms have < 50 employees 24
  • 25. Major Global Investors in Canada 25
  • 26. Leading Canadian Companies (Some Examples) Company Focus TAXUS® drug-eluting Angiotech coronary stent ART Optical molecular imaging EastMed Uresta® bladder support Blood diagnostic system in Epocal FlexCard™ technology IMRISneuro, Intra- IMRIS operative MRI Radiological imaging & MDS Nordion isotopes Novadaq Operating room imaging Technologies Pyng Medical First Aid Devices Resonant Medical 3D Ultrasound Imaging Urodynamix Urology diagnostics 26
  • 27. Leading Canadian Companies (Some Examples) Company Focus Axela Protein interaction technology BrightWELL Micro-Flow imaging technology Techologies (MFI) for cell analysis DNA collection & preservation DNA Genotek systems QBM Cell Science Cryopreserved mouse neurons Advanced medical polymers & Rimon Therapeutics biomaterials for wound care Spartan Biosciences Personal DNA analyzers Fast testing of Sepsis & West Spectral Diagnostic Nile Virus 27
  • 28. Medical Device Strengths In-vitro diagnostics Medical imaging & analysis Nuclear medicine Surgical & implant devices Advanced materials & nanotechnology 28
  • 29. In-Vitro Diagnostics Examples Include: Epocal’s Blood Diagnostic Spectral Diagnostic’s System in FlexCard™ Testing Kit for West Nile Technology Virus 29
  • 30. Medical Imaging & Analysis Examples Include: ART’s SoftScan IDC’s DR System Breast Imaging Device 30
  • 31. Nuclear Medicine Examples Include: MDS Nordion’s Glucotrace® for Cardiology and Oncology Diagnoses using PET Isotopes 31
  • 32. Surgical & Implant Devices Examples Include: Angiotech’s Drug-Eluting Coronary Stents EastMed’s Uresta® for Stress Urinary Incontinence for Women 32
  • 33. Latest Innovation World’s First Simulation-Based Brain Surgery Done in Halifax, Canada 2009.08 33
  • 34. Canada’s Contract Services Subsector THEN: Provided backup supply services to multinational pharmaceutical companies NOW: Grown and become technologically sophisticated World renowned for quick recruiting Adheres to GCP protocols & generates high quality, robust data 4th worldwide in overall share of global clinical trials Top 10 pharmaceutical companies consistently include Canada in clinical development plans & new drug submission data packages
  • 35. Contract Services: Strengths Contract manufacturers (CMOs) Clinical research organizations (CROs) Design & manufacturing of high value medical devices (surgical devices, implants, imaging systems) Analytical services Regulatory affairs & compliance 35
  • 36. Leading Canadian Companies Company Focus Research contracting organization specializing in pre-clinical, phase I & bioequivalence Algorithme Pharma studies Clinical trial management company managing multi-site trials & sourcing trial services Allphase Clinical Research globally Manufacturing contracts for both large and small-molecule Advanced Pharmaceutical Biovectra Ingredients (API’s), advanced intermediates, and cGMP bioprocessing reagents MDS Pharma Service Research contracting organization that provides drug discovery and development services Manufacturing contractors committed to the development, manufacturing, purification, and Therapure Biopharma packaging of high-quality biological therapeutics Wellspring Pharmaceutical Manufacturing contracts for specialized dosage forms for clinical & commercial distribution 36
  • 37. Clinical Trials by Condition Source: ClinicalTrials.gov, Dec. 2008 37
  • 38. Clinical Trials by Sponsor 38
  • 40. Emerging Biotech Cluster Why is Canada interested? Top 10 US biotech clusters US $10b+ NIH funding, most research intensive country in the world, 50% and 40% of global patent applications in med tech and pharma/biotech products, respectively Paradigm shift: globalization of industry and BigPharma looking to fill innovation gap as blockbuster revenue cliff approaches Weaknesses in Florida VC funding Training/Tertiary Education/Skilled Labour Entrepeneurship 40
  • 42. Strategic Context Post-recession • Technology based firms need international linkages to position themselves for the post-recession economy. • By partnering with other countries on science and technology, firms connect to knowledge, know-how, people, investments and markets abroad. • They also respond to new business model where “biotech clusters will be redefined away from geography and be more virtual built around diseases, pathways, markets, and unique industry segments”. (Burrill & Co. Biotech 2010 – Life Sciences: Adapting for Success). Credit Crunch, Public & Private Capital Drought • VC funding lowest in 15 years both in Canada and the U.S.: ($1 billion in Canada, $235 million in Florida) – however healthcare surpassed IT or cleantech. • PE/Buyout market: Canada 4th in volume, 18th in value of M&A deals, however Canadian funds raised close to $20 billion in 2006-2008 so considerable available capital to deploy. • Only 3 biotech IPOs in 2009, but Burrill expects pick-up to 15 IPOs in 2010 42
  • 43. Five major factors drive foreign interest in collaborations Attractions include Canada’s: • Strong and stable economy • First-class technological infrastructure • Highly skilled workforce • Lower business and R&D cost structure • Investment incentive programs: the best research incentives in the world 43
  • 44. Workforce: Educated & Available Higher Education Achievement 55 54,0 53,0 51,4 51,0 50,0 50 47,8 45 % 41,0 41,0 41,0 40,0 40,0 39,8 40 39,0 39,0 35 30 a ng e k um De y da ce an d n Ho ain l S. ae re ar a So por lan pa Ko rw na U. an iw nm Ko Sp lgi Isr Ja Ire a Ta No Fr Ca Be ng ng h ut Si Source: IMD, World Competitiveness Yearbook 2008 44
  • 45. Workforce: Educated & Available Source: IMD, World Competitiveness Yearbook 2008 45
  • 49. Canada: An Innovation Leader Canada generates about 4% of global knowledge, as measured by academic publications, a formidable statistic considering it composes only 1% of the global population. Canada leads the G7 in public sector research funding on a per capita basis. Canada has one of the most generous tax-based support programs in the industrialized world through the Scientific Research & Experimental Development tax credit. 49
  • 50. Canadian Life Sciences Innovation Canada’s health science research community consists of over 64,000 physicians, 30,000 investigators in 17 medical schools, and over 100 teaching hospitals and research institutes. Canadian innovators are internationally recognized for research and product development excellence in genomics,proteomics, vaccine development, medical devices, regenerative medicine (stem cells), protein engineering, immunotherapies and drug delivery systems. Canada Canadian life sciences discoveries: insulin, pacemaker, sequencing Alzheimer genome & H1N1 genome, adult stem cells, how stem cells become blood cells, embryonic stem cells from skin, etc. 50
  • 51. Canadian university R&D funding programs • Canadian Institutes of Health Research (CIHR) • Canada Foundation for Innovation (CFI) • Canada Research Chairs (CRC) • Genome Canada • Networks of Centres of Excellence (NCE) • Department of Foreign Affairs and International Trade • National Research Council: • 15 Industrial Partnership Facilities (IPF) business incubators affiliated with NRC’s 21 research institutes -137 firms, 13 graduates 08-09 • Industry Research Assistance Program (IRAP) works with 8000 SMEs, youth internships, Angiotech (anti- inflammation tech) in 5 years $30 milllions 1,500 jobs 51
  • 52. Innovation and Sector Interface Life Sciences ICT Clean Tech Aerospace $ Pu Valley of b lic Death e iv at Pr Mind Market 52
  • 53. Investment Growth Capital 2009 TSX: 28 IPOs, $1.8billion TSX-V: 20 IPOs, $69 million 2010 (projected) TSX & TSX-V: $4 billion IPO market 53
  • 54. Events in Canada BioPartnering North America, Vancouver, Jan 24-26, 2010 BioFinance, Toronto, 6-8 April, 2010 BioContact, Quebec City, Oct. 6-7, 2010 54
  • 61. Conclusion Tap into Canadian ideas, knowledge and talent – through strategic alliances, joint ventures, licensing and technology transfer agreements, and venture capital as well as public and private equity investments. Explore the opportunities to make Canadian innovators your technology development and commercialization partners. 61
  • 62. Contact Info http://twitter.com/claudiopramirez http://www.linkedin.com/in/claudiopramirez http://www.facebook.com/claudiopramirez